Article Information
History
- August 26, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Issam Raad*,1,
- Ray Hachem*,1,†,
- Nigo Masayuki2,
- Tarcila Datoguia3,
- Hiba Dagher1,
- Ying Jiang1,
- Vivek Subbiah4,5,
- Bilal Siddiqui6,
- Arnaud Bayle7,
- Robert Somer8,
- Ana Fernández Cruz9,
- Edward Gorak10,
- Arvinder Bhinder11,
- Nobuyoshi Mori12,
- Nelson Hamerschlak3,
- Samuel Shelanski13,
- Tomislav Dragivich14,
- Yee Elise Vong Kiat15,
- Suha Fakhreddine16,
- Pierre Abi Hanna16,
- Roy F. Chemaly1,
- Victor Mulanovich1,
- Javier Adachi1,
- Jovan Borjan1,
- Fareed Khawaja1,
- Bruno Granwehr1,
- Teny John1,
- Eduardo Yepez Guevara1,
- Harrys Torres1,
- Natraj Reddy Ammakkanavar4,
- Marcel Yibirin1,
- Cielito C Reyes-Gibby17,
- Mala Pande18,
- Noman Ali19,
- Raniv Dawey Rojo20,
- Shahnoor M Ali1,
- Rita E Deeba1,
- Patrick Chaftari17,
- Takahiro Matsuo12,
- Kazuhiro Ishikawa12,
- Ryo Hasegawa12,
- Ramón Aguado-Noya21,
- Álvaro García-García22,
- Cristina Traseira Puchol21,
- Dong-Gun Lee23,
- Monica Slavin24,
- Benjamin Teh24,
- Cesar A Arias2,
- Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team25,
- Dimitrios P. Kontoyiannis1,
- Alexandre E. Malek1 and
- Anne-Marie Chaftari*,†,1
- 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 2Division of Infectious Diseases, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
- 3Médica Hematologista Hospital Israelita Albert Einstein, São Paulo, Brasil
- 4Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 5MD Anderson Cancer Network, UT MD Anderson Cancer Center, Houston, Texas, USA
- 6Department of Hematology Oncology, Community Health Network, Indiana, USA
- 7Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France
- 8Cooper Medical School of Rowan University, Cooper University Health Care, Camden, New Jersey, USA
- 9Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro, Madrid, Spain
- 10Department of Hematology Oncology, Baptist Health, Jacksonville, Florida, USA
- 11Department of Hematology/Oncology, Ohio Health Marion, Ohio, USA
- 12Department of Infectious Diseases, St. Luke’s International Hospital, Tokyo, Japan
- 13Banner MD Anderson Cancer Center – North Colorado, Greely, Colorado, USA
- 14Division of Cancer Medicine, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA
- 15Department of Medical Oncology, Tan Tock Seng Hospital, Singapore
- 16Department of Infectious Diseases, Rafik Hariri University Hospital, Beirut, Lebanon
- 17Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 18Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 19Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 20Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
- 21Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
- 22Hematology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
- 23Division of Infectious Diseases, Department of Internal Medicine, Vaccine Bio Research Institute, The Catholic University of Korea, Seoul, Korea
- 24Department of Infectious Diseases and National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- 25Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team at The University of Texas MD Anderson Cancer Center, Houston, TX
- ↵†Corresponding Author Corresponding authors: Anne-Marie Chaftari & Ray Hachem, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1460, Houston, TX 77030, USA. Tel: 713-792-3491, Email: achaftari{at}mdanderson.org; rhachem{at}mdanderson.org
↵* Contributed equally